Introduction
Various options for extracorporeal support
-
In the veno-venous configuration, the artificial and the natural lung are connected in series, as the blood flow entering the membrane lung is re-directed into the natural lung, after the artificial gas exchange. The hemodynamics are not affected by this configuration, which works solely as a respiratory support. In contrast, in the veno-arterial configuration, the artificial and the natural lung are arranged in parallel: the flow leaving the artificial lung is diverted in the arterial section and the natural lung is proportionally under-perfused. The greatest difference between veno-venous and veno-arterial approach is not related to the gas exchange, as the amount of oxygen transferred and CO2 removed are exactly the same (if the operating conditions of the membrane lung are the same), but to the hemodynamic impact, as the veno-arterial configuration provides both respiratory and cardiac support.
-
The second feature is the amount of blood flow and gas flow used to ventilate the artificial lung: to oxygenate venous blood entering the membrane lung, the gas flow required equals the oxygen sufficient to fully saturate the hemoglobin passing through the artificial lung. As an example, if 1 l of venous blood with10 g/dL of hemoglobin and saturation 70% enters the membrane lung every minute, a transfer of 42 ml of 100% oxygen per minute from the gas compartment of the membrane lung would be sufficient to fully saturate the blood leaving the membrane lung. Therefore, being the possibility to “charge” oxygen limited by the hemoglobin concentration and its saturation in the venous blood, the oxygen transfer to the membrane lung is primarily function of the extracorporeal blood flow. In the previous example, 4 l of extracorporeal blood flow, in the absence of re-circulation, would provide fully saturated blood with a gas flow into the membrane lung of only 168 ml/min. All the gas is absorbed, and no gas leaves the membrane lung
Renal hemodialysis | Extracorporeal removal of carbon dioxide | Extracorporeal oxygenation | |
---|---|---|---|
Extracorporeal blood flow (ml/min) | 200–300 | 500–1000 | 2000–4000 |
Blood pumping | optional | optional | required |
Hemodynamic changes | small | small | major |
Vascular access | A-V shunt or A-V fistula | A-V shunt or A-V fistula or V-V pumping | V-A or V-V |
Surgical complexity | simple | simple | complex |
Complexity of equipment | moderate | simple | advanced |
Requirement for heparin | small | small | large |
Rationale
-
Rescue intervention for tissue hypoxia, primarily due to respiratory failure (high-flow veno-venous ECMO) [5]
-
Reduction of mechanical ventilation and related damages in ARDS [6‐8], status asthmaticus [9, 10], and COPD exacerbation (low-flow ECCO2R or minimally invasive ECCO2R) [11, 12]. To this, another possible use of minimally invasive ECCO2R may be considered for COPD patients in order to improve the quality of life by programmed CO2 dialysis [13]
Rescue high-flow V-V ECMO
Study | Patients enrolled | Inclusion criteria |
---|---|---|
NIH adult ECMO trial Zapol et al. 1979, JAMA | 90 | Severe ARF: -PaO2 < 50 mmHg for at least 2 h despite 100% FIO2 and 5 cmH2O of PEEP (fast entry) -PaO2 < 50 mmHg for at least 12 h despite 60% FIO2 and 5 cmH2O of PEEP or a Qs/Qt > 30% with 100% of FIO2 and 5 cmH2O PEEP |
PCIRV vs ECCO2R Morris, 1994, Am J Respir Crit Care Med | 40 | -ARDS (defined as P(a/A)O2 < 0.2, bilateral chest radiographic infiltrates, total compliance < 50 ml/cmH2O, wedge pressure < 15 mmHg and no signs of heart failure) |
-ECMO criteria: - PaO2 < 50 mmHg for at least 2 h despite 100% FIO2 and 5 cmH2O of PEEP (fast entry) - PaO2 < 50 mmHg or Qs/Qt > 30% for at least 12 h despite 60% FIO2 and 5 cmH2O of PEEP, in a > 48 h ICU patients (slow entry) | ||
CESAR trial Peek et al. 2009, Lancet | 180 | -Severe but potentially reversible respiratory failure (Murray score > 2.5 or hypercapnia with arterial pH < 7.2) |
-Age 18–65 | ||
-Ventilation/high FIO2 < 7 days | ||
-No cranial bleeding | ||
-No contraindication to heparin | ||
-No contraindication to continuation of the active treatment | ||
EOLIA trial Combes et al. 2018, NEJM | 249 | -ARDS |
-Mechanical ventilation < 7 days | ||
-With (despite ventilator optimization): • PaO2/FIO2 < 50 for at least 3 h • PaO2/FIO2 < 80 for at least 6 h • Arterial pH < 7 .25 with PaCO2 > 60 mmHg for at least 6 h |
Low-flow extracorporeal CO2 removal
Extracorporeal support: when to start
High-flow veno-venous ECMO
-
The oxygen transfer in the natural lung decreases proportionally to the increase of oxygen saturation of hemoglobin perfusing the open lung units. Indeed, the PO2 in the pulmonary capillaries, perfusing the open lung units, only depends on FIO2, barometric pressure, and respiratory quotient. Therefore, the drive for the oxygen transfer in the natural lung is the difference between PAO2 (equal to the pulmonary capillary partial pressure) and the PVO2/saturation of the blood entering the venous side. Higher PvO2 and oxygen saturation implies decrease of oxygen transfer. It is worth to understand that the capillary PO2 of the ideally perfused pulmonary unit does not change, whatever is the ECMO blood flow.